Compugen (CGEN) EBIT Margin Growth (1y) (2010 - 2026)

Compugen (CGEN) EBIT Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -170.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1,276.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Compugen 215.59 Mn 123.84 Mn 352,000.00 4,683.00

Historic Data

Download Data
DateValue
Mar 31, 2026 4,683.00
Dec 31, 2025 59,194.00
Sep 30, 2025 -44,364.00
Jun 30, 2025 -170,196.00
Mar 31, 2025 3,571.00
Dec 31, 2024 -56,245.00
Dec 31, 2023 10,080.00
Dec 31, 2016 -1.65 Mn
Sep 30, 2016 -836,221.00
Jun 30, 2016 170,503.00
Mar 31, 2016 -830,635.00
Dec 31, 2015 827.00
Sep 30, 2015 -275,187.00
Jun 30, 2015 -294,900.00
Mar 31, 2015 -107,713.00
Dec 31, 2014 20,597.00
Sep 30, 2014 951.00
Jun 30, 2014 2.13 Mn
Mar 31, 2014 229,169.00
Dec 31, 2013 264,343.00